Notice of Closed Meeting; Correction, 16360-16361 [2018-07835]

Download as PDF 16360 Federal Register / Vol. 83, No. 73 / Monday, April 16, 2018 / Notices (ABRWH), Centers for Disease Control and Prevention, Department of Health and Human Services, has been renewed for a 2-year period through March 22, 2020. FOR FURTHER INFORMATION CONTACT: Theodore Katz, Designated Federal Officer, NIOSH, CDC, 1600 Clifton Road NE, MS E–20, Atlanta, Georgia 30329– 4027, telephone (513) 533–6800, toll free: 1–800–CDC–INFO, email: dcas@ cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2018–07770 Filed 4–13–18; 8:45 am] Agenda: To review and evaluate grant applications. FOR FURTHER INFORMATION CONTACT: Mikel Walters, Ph.D., Scientific Review Official, NCIPC, CDC, 4770 Buford Highway NE, Mailstop F–63, Atlanta, Georgia 30341, Telephone: (404) 639– 0913; Email: mwalters@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2018–07814 Filed 4–13–18; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4163–18–P Centers for Disease Control and Prevention DEPARTMENT OF HEALTH AND HUMAN SERVICES Mine Safety and Health Research Advisory Committee (MSHRAC) Centers for Disease Control and Prevention Notice of Closed Meeting srobinson on DSK3G9T082PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—RFA–CE–18–004, Research to Evaluate Medication Management of Opioids and Benzodiazepines to Reduce Older Adult Falls. Dates: June 6, 2018 and June 7, 2018. Time: 9:00 a.m.–5:00 p.m., EDT. Place: DoubleTree by Hilton Hotel Atlanta—Buckhead, 3342 Peachtree Road NE, Atlanta, GA 30326. VerDate Sep<11>2014 19:42 Apr 13, 2018 Jkt 244001 Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Mine Safety and Health Research Advisory Committee (MSHRAC). This meeting is open to the public, limited only by the space available. The meeting room accommodates approximately 33 people. If you wish to attend in person or by phone, please contact Marie Chovanec by email at MChovanec@ cdc.gov or by phone at 412–386–5302 at least 5 business days in advance of the meeting. DATES: The meeting will be held on May 22, 2018, 8:30 a.m.–4:00 p.m., EDT and May 23, 2018, 8:00 a.m.–12:00 p.m. EDT. SUMMARY: Department of Health and Human Services; the Director, CDC; and the Director, NIOSH, on priorities in mine safety and health research, including grants and contracts for such research, 30 U.S.C. 812(b)(2), Section 102(b)(2). Matters to be Considered: The meeting will focus on mining safety and health research projects and outcomes, including end-of-shift silica monitor; iLOTO iFund project; miner health program; research & practice to protect miners’ hearing health; stone, sand, & gravel sector research priorities; mining program collaborations; and mining innovations research initiative update. The meeting will also include updates from the National Personal Protective Technology Laboratory and the Respiratory Health Division. Agenda items are subject to change as priorities dictate. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2018–07761 Filed 4–13–18; 8:45 am] BILLING CODE 4163–19–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of Closed Meeting; Correction Notice is hereby given of a change in the meetings of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—GH14– 002, Addressing Emerging Infectious Diseases in Bangladesh; GH16–003, Conducting Public Health Research in Thailand: Technical collaboration with the Ministry of Public Health in the Kingdom of Thailand (MOPH); GH16– 006, Conducting Public Health Research ADDRESSES: Patriots Plaza 1, 395 E Street in Kenya; GH17–005, Conducting Public SW, Room 9000, Washington, DC 20201. Health Research in China; April 10, FOR FURTHER INFORMATION CONTACT: 2018, 9:00 a.m.–2:00 p.m., EDT, which Jeffrey H. Welsh, Designated Federal was published in the Federal Register Officer, MSHRAC, NIOSH, CDC, 626 on March 20, 2018, Volume 83, Number Cochrans Mill Road, Pittsburgh, PA 54, pages 12193–12194, and the Disease, 15236, telephone 412–386–4040, fax Disability, and Injury Prevention and 412–386–6614. Control Special Emphasis Panel (SEP)— GH18–002, Strengthening detection of SUPPLEMENTARY INFORMATION: emerging infectious diseases in India; Purpose: This committee is charged GH18–005, Enhancing Capacity for with providing advice to the Secretary, PO 00000 Frm 00076 Fmt 4703 Sfmt 4703 E:\FR\FM\16APN1.SGM 16APN1 Federal Register / Vol. 83, No. 73 / Monday, April 16, 2018 / Notices Strategic and Applied Research Activities in Support of Control and Elimination of Malaria and Neglected Tropical Diseases; April 18, 2018, 9:00 a.m.–2:00 p.m., EDT, which was published in the Federal Register on March 20, 2018, Volume 83, Number 54, page 12194. The title, date and time should read as follows: Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—GH14–002, Addressing Emerging Infectious Diseases in Bangladesh; GH16–003, Conducting Public Health Research in Thailand: Technical collaboration with the Ministry of Public Health in the Kingdom of Thailand (MOPH); GH16–006, Conducting Public Health Research in Kenya; GH17–005, Conducting Public Health Research in China; GH18–002, Strengthening detection of emerging infectious diseases in India; GH18–005, Enhancing Capacity for Strategic and Applied Research Activities in Support of Control and Elimination of Malaria and Neglected Tropical Diseases. Date: May 2, 2018. Time: 9:00 a.m.–2:00 p.m., EDT. Place: Teleconference. For Further Information Contact: Hylan Shoob, Ph.D., Scientific Review Officer, Center for Global Health, CDC, 1600 Clifton Drive, Atlanta, GA 30331, telephone (404) 639–4796; email HShoob@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—Single-Source Supplement CK15–002, Sentinel Enhanced Dengue Surveillance System (SEDSS) Sites to Evaluate the Epidemiology and Prevention of Dengue and other Acute Febrile Illnesses in Puerto Rico. Date: June 7, 2018. Time: 10:00 a.m.–12:00 p.m., EDT. Place: Teleconference, Centers for Disease Control and Prevention, Room 1080, 8 Corporate Square Blvd., Atlanta, GA 30329. Agenda: To review and evaluate grant applications. For Further Information Contact: Gregory Anderson, MS, MPH, Scientific Review Officer, CDC, 1600 Clifton Road NE, Mailstop E60, Atlanta, Georgia 30333, (404) 718–8833, gca5@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Elaine Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2018–07816 Filed 4–13–18; 8:45 am] [FR Doc. 2018–07835 Filed 4–13–18; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4163–18–P Centers for Disease Control and Prevention DEPARTMENT OF HEALTH AND HUMAN SERVICES Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC)—State, Tribal, Local and Territorial Subcommittee (STLT) Centers for Disease Control and Prevention srobinson on DSK3G9T082PROD with NOTICES Notice of Closed Meeting 19:42 Apr 13, 2018 Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of VerDate Sep<11>2014 BILLING CODE 4163–18–P Jkt 244001 In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Advisory Committee to the Director, Centers for Disease Control SUMMARY: PO 00000 Frm 00077 Fmt 4703 Sfmt 4703 16361 and Prevention—State, Tribal, Local and Territorial Subcommittee (ACD, CDC– STLT). This meeting is open to the public, limited only by the room seating, audio phone lines and net conference access available. The public is also welcome to listen to the meeting by dialing (877) 692–1879, entering participant code 57852858, with 100 ports available. The public comment period is from 2:00 p.m.–2:15 p.m. No advance registration is required. The meeting will be held on August 2, 2018, 8:30 a.m. to 4:00 p.m., EST. DATES: Centers for Disease Control and Prevention, Building 19, Rooms 245–246, 1600 Clifton Road NE, Atlanta, Georgia 30329. This meeting is also available by teleconference. Please dial (877) 692–1879 and enter code 57852858. ADDRESSES: Jose Montero, MD, Designated Federal Officer, STLT Subcommittee, ACD, CDC, 4770 Buford Hwy, MS E70, Atlanta, GA 30341, Telephone (404) 498–0259, Email: OSTLTSDirector@ cdc.gov. FOR FURTHER INFORMATION CONTACT: SUPPLEMENTARY INFORMATION: Purpose: The Subcommittee will provide counsel to the ACD on strategies, future needs, and challenges faced by State, Tribal, Local and Territorial health agencies, and will provide guidance on opportunities for CDC through the ACD. Matters to be Considered: The agenda will include discussions on implementation of ACD-adopted recommendations related to the health department of the future, other emerging challenges, and how CDC can best support STLT health departments in the transforming health system. Agenda items are subject to change as priorities dictate. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2018–07772 Filed 4–13–18; 8:45 am] BILLING CODE 4163–19–P E:\FR\FM\16APN1.SGM 16APN1

Agencies

[Federal Register Volume 83, Number 73 (Monday, April 16, 2018)]
[Notices]
[Pages 16360-16361]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-07835]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting; Correction

    Notice is hereby given of a change in the meetings of the Disease, 
Disability, and Injury Prevention and Control Special Emphasis Panel 
(SEP)--GH14-002, Addressing Emerging Infectious Diseases in Bangladesh; 
GH16-003, Conducting Public Health Research in Thailand: Technical 
collaboration with the Ministry of Public Health in the Kingdom of 
Thailand (MOPH); GH16-006, Conducting Public Health Research in Kenya; 
GH17-005, Conducting Public Health Research in China; April 10, 2018, 
9:00 a.m.-2:00 p.m., EDT, which was published in the Federal Register 
on March 20, 2018, Volume 83, Number 54, pages 12193-12194, and the 
Disease, Disability, and Injury Prevention and Control Special Emphasis 
Panel (SEP)--GH18-002, Strengthening detection of emerging infectious 
diseases in India; GH18-005, Enhancing Capacity for

[[Page 16361]]

Strategic and Applied Research Activities in Support of Control and 
Elimination of Malaria and Neglected Tropical Diseases; April 18, 2018, 
9:00 a.m.-2:00 p.m., EDT, which was published in the Federal Register 
on March 20, 2018, Volume 83, Number 54, page 12194.
    The title, date and time should read as follows:

    Name of Committee: Disease, Disability, and Injury Prevention 
and Control Special Emphasis Panel (SEP)--GH14-002, Addressing 
Emerging Infectious Diseases in Bangladesh; GH16-003, Conducting 
Public Health Research in Thailand: Technical collaboration with the 
Ministry of Public Health in the Kingdom of Thailand (MOPH); GH16-
006, Conducting Public Health Research in Kenya; GH17-005, 
Conducting Public Health Research in China; GH18-002, Strengthening 
detection of emerging infectious diseases in India; GH18-005, 
Enhancing Capacity for Strategic and Applied Research Activities in 
Support of Control and Elimination of Malaria and Neglected Tropical 
Diseases.
    Date: May 2, 2018.
    Time: 9:00 a.m.-2:00 p.m., EDT.
    Place: Teleconference.
    For Further Information Contact: Hylan Shoob, Ph.D., Scientific 
Review Officer, Center for Global Health, CDC, 1600 Clifton Drive, 
Atlanta, GA 30331, telephone (404) 639-4796; email [email protected].

    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

Elaine Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2018-07835 Filed 4-13-18; 8:45 am]
 BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.